Interim Evaluation of Respiratory Syncytial Virus Hospitalization Rates Among Infants and Young Children After Introduction of Respiratory Syncytial Virus Prevention Products - United States, October 2024-February 2025.
Saved in:
| Title: | Interim Evaluation of Respiratory Syncytial Virus Hospitalization Rates Among Infants and Young Children After Introduction of Respiratory Syncytial Virus Prevention Products - United States, October 2024-February 2025. |
|---|---|
| Authors: | Patton ME, Moline HL, Whitaker M, Tannis A, Pham H, Toepfer AP, Taylor CA, Goldstein L, Reingold A, Kirley PD, Alden NB, Kawasaki B, Meek J, Kim D, Witt LS, Openo KP, Ryan PA, Mumm E, Lynfield R, Salazar-Sanchez Y, Pacheco F, Keating F, Anderson BJ, Tesini BL, Felsen CB, Sutton M, Thomas A, Schaffner W, Talbot HK, Harbi K, Doran E, Weinberg GA, Staat MA, Payne DC, Halasa NB, Stewart L, Boom JA, Sahni LC, Klein EJ, Englund JA, Williams JV, Michaels MG, Schuster JE, Selvarangan R, Szilagyi PG, Havers FP, Dawood FS |
| Source: | MMWR. Morbidity and mortality weekly report [MMWR Morb Mortal Wkly Rep] 2025 May 08; Vol. 74 (16), pp. 273-281. Date of Electronic Publication: 2025 May 08. |
| Publication Type: | Comparative Study; Journal Article |
| Journal Info: | Publisher: U.S. Centers for Disease Control Country of Publication: United States NLM ID: 7802429 Publication Model: Electronic Cited Medium: Internet ISSN: 1545-861X (Electronic) Linking ISSN: 01492195 NLM ISO Abbreviation: MMWR Morb Mortal Wkly Rep Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
